Anbio Biotechnology Ltd - NNNN Net Assets per Single Share

Graphic logo of Anbio Biotechnology Ltd (NNNN)

Anbio Biotechnology (NNNN) complies with environmental regulations regarding chemical disposal and energy efficiency in its laboratories. The implementation of AI platforms and diagnostic automation eliminates human error, as evidenced by this price chart reflecting changes where the indicator stands at 0.80. The business model relies on a sophisticated temperature-controlled reagent delivery system that guarantees the integrity of tests during transport.

Anbio Biotechnology Ltd (NNNN) - Accounting Value per Share from 02/20/2025 to 10/27/2026

Summary analytical data breakdowns for anbio.com (NNNN)

- price and consensus price forecast:
Price Chart Anbio Tech|NNNN - Broker Consensus Forecast
- market capitalization data:
Market Value Anbio|NNNN - Business Value
- book capitalization data:
Net Assets per Single Share Anbio Biotechnology|NNNN - Company Net Assets|Market Capitalization to Book Value Ratio anbio.com|NNNN - Company Assets
- debt and liquidity data:
Total Debt to Capital Anbio Biotechnology|NNNN - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Anbio|NNNN - Company Aggregate Debts|Debt to Book Capitalization Ratio Anbio
Fundamental company valuation:Anbio Biotechnology
Manufactured product of anbio.com

Book value per share reflects the portion of net equity attributable to a single security after deducting all liabilities. Investors utilize this metric to assess the intrinsic value of a business away from market noise. By analyzing the book value per share trend, one can track the real growth of a company's resources. For Anbio Biotechnology (NNNN), this confirms the effectiveness of diversifying its diagnostic systems. The expansion of global equipment sales directly capitalizes the enterprise's assets.

Competitors of Anbio Biotechnology (NNNN)

Agilent Tech (A) - Net Assets per Single Share|DGX: Equity per Share|Net Assets per Single Share Illumina, Inc.|EXAS (exactsciences.com) - Equity per Share|Net Assets per Single Share RVTY|Accounting Value per Share Bio-Rad Laboratories, Inc.|Sterigenics - Book Value per Share|Net Asset Value per Share QuidelOrtho Inc. (QDEL)|OPK - Book Value per Share|Equity per Share CareDx Health CDNA|Maravai LifeSciences Holdings, Inc. - Book Value per Share|FLGT: Book Value per Share|Net Assets per Single Share Fluidigm|Cytek Corp (CTKB) - Equity per Share|OSUR (OraSure Technologies) - Book Value per Share|Book Value per Share XGN|Net Assets per Single Share MDxHealth (MDXH)|Net Assets per Single Share Lucid Diagnostics, Inc. LUCD|PRE: Accounting Value per Share|Insight Molecular Diagnostics, Inc. - Net Asset Value per Share|Net Assets per Single Share TRIB (Trinity Biotech Corp)|PRPH - Net Assets per Share|Ainos - Book Value per Share|CODX (Co-Diagnostics Inc) - Net Assets per Share|HSCS: Net Assets per Single Share|Net Assets per Share Biomerica Inc|Book Value per Share CDIO|Book Value per Share VRAX (viraxbiolabs.com)|BJDX - Net Assets per Single Share|Equity per Share Aspira Women's Health, Inc. AWH|AXDX - Book Value per Share|CNTG - Net Assets per Single Share|enzo.com - Book Value per Share|FRES (Fresh2 Group) - Net Assets per Share|Net Assets per Single Share GENE (Genetic Technologies Ltd)|Net Asset Value per Share 23andMe Holding Co (ME)|Psychemedics Corp (PMD) - Accounting Value per Share